Related Experiment Video
Updated: Oct 19, 2025

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
Published on: September 1, 2015
Insights Into the Molecular Mechanisms of Polycystic Kidney Diseases
Valeriia Y Vasileva1, Regina F Sultanova2,3, Anastasia V Sudarikova1
1Institute of Cytology, Russian Academy of Sciences, St. Petersburg, Russia.
Insights
Polycystic kidney disease (PKD) involves kidney cyst growth, leading to renal failure. This review explores PKD mechanisms and potential non-drug therapies like diet to manage the condition.
Area of Science:
- Nephrology
- Genetics
- Molecular Biology
Background:
- Autosomal dominant (AD) and autosomal recessive (AR) polycystic kidney diseases (PKD) are severe genetic disorders causing kidney cyst formation and renal function loss.
- Current treatments are limited; tolvaptan offers modest ADPKD symptom relief but has side effects and doesn't halt progression.
Purpose of the Study:
- To review fundamental mechanisms driving PKD development, focusing on ADPKD.
- To explore molecular cascades, systemic responses, and non-pharmacological therapies for PKD.
Main Methods:
- Literature review of current knowledge on PKD pathogenesis.
- Analysis of PC1/PC2 pathways, cilia-associated mechanisms, metabolism, mitochondrial function, and systemic factors.
- Examination of non-pharmacological interventions, including dietary approaches.
Main Results:
- Highlights key pathways (PC1/PC2, cilia) and molecular cascades (metabolism, mitochondria) implicated in PKD.
- Discusses systemic influences: hormonal status, growth factors, immune system, and microbiome.
- Reviews emerging non-pharmacological therapies, such as dietary interventions.
Conclusions:
- A deeper understanding of PKD mechanisms is crucial for developing effective treatments.
- Non-pharmacological strategies, particularly dietary modifications, show promise for alleviating PKD symptoms and progression.
Abstract:
Autosomal dominant (AD) and autosomal recessive (AR) polycystic kidney diseases (PKD) are severe multisystem genetic disorders characterized with formation and uncontrolled growth of fluid-filled cysts in the kidney, the spread of which eventually leads to the loss of renal function. Currently, there are no treatments for ARPKD, and tolvaptan is the only FDA-approved drug that alleviates the symptoms of ADPKD. However, tolvaptan has only a modest effect on disease progression, and its long-term use is associated with many side effects. Therefore, there is still a pressing need to better understand the fundamental mechanisms behind PKD development. This review highlights current knowledge about the fundamental aspects of PKD development (with a focus on ADPKD) including the PC1/PC2 pathways and cilia-associated mechanisms, major molecular cascades related to metabolism, mitochondrial bioenergetics, and systemic responses (hormonal status, levels of growth factors, immune system, and microbiome) that affect its progression. In addition, we discuss new information regarding non-pharmacological therapies, such as dietary restrictions, which can potentially alleviate PKD.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Nephrons
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Renal Tubule and Collecting Duct
Proximal Convoluted Tubule (PCT):
The PCT is the initial segment of the renal tubule, extending from the Bowman's capsule that encloses the glomerulus. Its convoluted structure and microvilli-lined cells increase the surface area for reabsorption. The PCT reabsorbs glucose, amino acids, sodium, and water from the filtrate, ensuring essential...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Chronic Kidney Disease II: Clinical Manifestations

